Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInna Chen, MD
About this trial
Pancreatic and biliary tract cancer are ones of the leading causes of cancer-related deaths. During the course of illness, these patients often experience marked physical suffering, psychological distress and frequent unplanned resource-demanding hospitalized care. Patients with pancreatic and lung cancer have highest rates of unplanned hospitalizations. Investigator initiated prospective "Study of Supportive Application with Integrated Patient-Reported Outcomes in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)" is to be initiated based on the great need for optimizing treatment care, reducing hospitalizations and improving outcomes.
Eligibility criteria
Qualifiers
Adult (aged 18 and over)
Confirmed by cytology or histology advanced lung (NSCLC) or pancreatic cancer
Written informed consent before any study procedures
Planning to receive 1st line systemic anticancer therapy within ≤2 weeks
Disqualifiers
No mobile device
Exhibiting signs of overt psychopathology or cognitive dysfunction
Any medical condition that the Investigator considers significant to compromise the safety of the patient or that impairs the interpretation of study assessments
Patient participating in another interventional study during the surveillance period. This is only relevant for studies that might interfere with the intervention. Participation in protocols related only to treatment will not preclude participation in the present study. Cases of doubt will be settled by the protocol responsible.
Trial design
Treatments tested in this trial
- Supportive application with integrated weekly PRO
Treatment groups
274 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov